Tumor necrosis factor receptor 1 associated periodic syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Mar 2026High-Intensity Laser Therapy for Trapezius Myofascial Pain (HILT-TRAP Study)

Neveen Abd El Maksoad Kohaf — NA

TrialNOT YET RECRUITING
Sep 2025Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins

Kun-Ta Chou

TrialNOT YET RECRUITING
May 2016TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Universitaire Ziekenhuizen KU Leuven — PHASE4

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Tumor necrosis factor receptor 1 associated periodic syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

ILARIS

(canakinumab)Orphan drugstandard

Novartis Pharmaceuticals Corporation

12.1 Mechanism of Action Canakinumab is a human monoclonal anti-human IL-1β antibody of the IgG1/κ isotype. Canakinumab binds to human IL-1β and neutr...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Tumor necrosis factor receptor 1 associated periodic syndrome.
Search all trials →
Search clinical trials for Tumor necrosis factor receptor 1 associated periodic syndrome

Recent News & Research

No recent news articles indexed yet for Tumor necrosis factor receptor 1 associated periodic syndrome.
Search PubMed for Tumor necrosis factor receptor 1 associated periodic syndrome

Browse all Tumor necrosis factor receptor 1 associated periodic syndrome news →

Specialist Network

Top 1 by expertise

View all Tumor necrosis factor receptor 1 associated periodic syndrome specialists →

Quick Actions